KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Short-term Investments (2016 - 2026)

Bio-Rad Laboratories has reported Short-term Investments over the past 18 years, most recently at $1.1 billion for Q1 2026.

  • Quarterly Short-term Investments fell 7.16% to $1.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Mar 2026, down 7.16% year-over-year, with the annual reading at $1.0 billion for FY2025, 14.07% down from the prior year.
  • Short-term Investments was $1.1 billion for Q1 2026 at Bio-Rad Laboratories, up from $1.0 billion in the prior quarter.
  • Over five years, Short-term Investments peaked at $1.3 billion in Q2 2023 and troughed at $5.6 million in Q2 2022.
  • The 5-year median for Short-term Investments is $1.0 billion (2025), against an average of $604.0 million.
  • The largest YoY upside for Short-term Investments was 23869.15% in 2023 against a maximum downside of 99.56% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $5.6 million in 2022, then changed by 0.0% to $5.6 million in 2023, then skyrocketed by 20907.14% to $1.2 billion in 2024, then dropped by 14.07% to $1.0 billion in 2025, then increased by 4.61% to $1.1 billion in 2026.
  • Per Business Quant, the three most recent readings for BIO's Short-term Investments are $1.1 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025).